← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Hikma Pharmaceuticals
-4.0%
Pharma / Pharmaceuticals and Generic Medicines
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebFinancial Growth
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Growth | Gross Profit Growth | EBIT Growth | Operating Income Growth | Net Income Growth | EPS Growth | EPS Diluted Growth | Weighted Average Shares Growth | Weighted Average Shares Diluted Growth | Dividends per Share Growth | Operating Cash Flow Growth | Free Cash Flow Growth | Ten Y Revenue Growth Per Share | Five Y Revenue Growth Per Share | Three Y Revenue Growth Per Share | Ten Y Operating CF Growth Per Share | Five Y Operating CF Growth Per Share | Three Y Operating CF Growth Per Share | Ten Y Net Income Growth Per Share | Five Y Net Income Growth Per Share | Three Y Net Income Growth Per Share | Ten Y Shareholders Equity Growth Per Share | Five Y Shareholders Equity Growth Per Share | Three Y Shareholders Equity Growth Per Share | Ten Y Dividend per Share Growth Per Share | Five Y Dividend per Share Growth Per Share | Three Y Dividend per Share Growth Per Share | Receivables Growth | Inventory Growth | Asset Growth | Book Value per Share Growth | Debt Growth | R&D Expense Growth | SGA Expenses Growth |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-12 | 0.1422 | 0.1365 | 0.3014 | 0.3014 | 0.0106 | 0.0487 | 0.0365 | -0.014 | -0.0116 | 0.1321 | 0.1471 | 0.3245 | 0.8786 | 0.5155 | 0.3122 | 0.6092 | 0.5428 | 0.4001 | -0.2006 | -0.2648 | -0.5289 | 0.9277 | 0.4233 | 0.1 | 2.1332 | 0.7796 | 0.2599 | 0.0154 | 0.1481 | 0.0467 | 0.043 | -0.0717 | 0.0347 | 0.2534 |
2022-12 | -0.0141 | -0.0484 | -0.5154 | -0.5154 | -0.5534 | -0.5418 | -0.5393 | -0.0303 | -0.0343 | 0.073 | -0.1692 | -0.2542 | 0.9899 | 0.3929 | 0.2321 | 1.5503 | 0.2818 | 0.2131 | 0.6479 | 1.2389 | -0.582 | 1.2475 | 0.5108 | 0.0895 | 2.9843 | 0.6644 | 0.3163 | -0.0051 | 0.1165 | 0.0226 | -0.102 | 0.5165 | 0.0069 | 0.043 |
2021-12 | 0.0905 | 0.0832 | 0.0051 | 0.0051 | -0.0232 | -0.082 | -0.0777 | -0.0211 | -0.021 | 0.0371 | 0.375 | 0.7041 | 1.3371 | 0.3205 | 0.2867 | 4.2239 | 1.1963 | 0.5479 | 3.4167 | 1.7396 | 0.5575 | 1.6546 | 0.0326 | 0.5188 | 2.9334 | 0.545 | 0.4649 | 0.1797 | -0.0819 | 0.0573 | 0.1733 | -0.0922 | 0.0437 | 0.0517 |
2020-12 | 0.0607 | 0.0461 | 0.1744 | 0.1744 | -0.1131 | -0.0669 | -0.0721 | -0.0247 | -0.0205 | 0.1828 | -0.0169 | -0.1608 | 1.6097 | 0.3708 | 0.2296 | 1.7242 | 0.069 | 0.0651 | 2.5528 | 0.4421 | 1.5199 | 1.3385 | 0.3465 | 0.434 | 3.1032 | 0.5308 | 0.4956 | 0.0392 | 0.3327 | 0.0521 | 0.0345 | 0.3605 | -0.0866 | -0.0607 |
Wait! There's more — sign up for free or log in